Programmed Cell Death 1 and Programmed Cell Death Ligand 1 Expression in Extranodal NK/T-Cell Lymphoma

被引：0
|
作者：
Jung, Ho Young
Kim, Wook Youn
Kim, Tae Min
Heo, Due Seog
Kim, Chul-Woo
Jeon, Yoon Kyung
机构：
[1] Konkuk Univ Sch Med, Seoul, South Korea
[2] Seoul Natl Univ Coll Med, Seoul, South Korea
来源：
LABORATORY INVESTIGATION | 2015年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1410
引用
收藏
页码：353A / 353A
页数：1
相关论文
共 50 条
  • [31] Programmed Cell Death Ligand 1 Expression in Canine Cancer
    Shosu, Kazuha
    Sakurai, Masashi
    Inoue, Kumi
    Nakagawa, Takayuki
    Sakai, Hiroki
    Morimoto, Masahiro
    Okuda, Masaru
    Noguchi, Shunsuke
    Mizuno, Takuya
    IN VIVO, 2016, 30 (03): : 195 - 204
  • [32] PROGRAMMED CELL DEATH-1 INTERACTION WITH PROGRAMMED CELL DEATH LIGAND REGULATES NEURONAL CELL DEATH IN THE MOUSE RETINA
    Gandhi, N. M.
    Sham, C.
    Chen, L.
    Yang, X.
    Sharpe, A. H.
    Freeman, G.
    Braun, J.
    Gordon, L.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2009, 57 (01) : 237 - 237
  • [33] PROGRAMMED CELL DEATH PROTEIN 1 AND PROGRAMMED DEATH LIGAND 1 EXPRESSION IN NEUROENDOCRINE CARCINOMAS OF THE URINARY BLADDER
    Acikalin, Arbil
    Bagir, Emine
    Inceman, Merve
    Deger, Mutlu
    Erdogan, Seyda
    POLISH JOURNAL OF PATHOLOGY, 2020, 71 (04) : 307 - 313
  • [34] Clinicopathological analysis of programmed cell death 1 and programmed cell death ligand 1 expression in the tumour microenvironments of diffuse large B cell lymphomas
    Kwon, Dohee
    Kim, Sehui
    Kim, Pil-Jong
    Go, Heounjeong
    Nam, Soo Jeong
    Paik, Jin Ho
    Kim, Young A.
    Kim, Tae Min
    Heo, Dae Seog
    Kim, Chul Woo
    Jeon, Yoon Kyung
    HISTOPATHOLOGY, 2016, 68 (07) : 1079 - 1089
  • [35] Expression of programmed cell death 1/programmed cell death ligand 1 in the tumor microenvironments of primary gastrointestinal diffuse large B cell lymphomas
    Liu, Yang
    Ma, Jing
    Yu, Kangjie
    Li, Mingyang
    Liu, Fang
    Yan, Qingguo
    Wang, Zhe
    Guo, Shuangping
    PATHOLOGY RESEARCH AND PRACTICE, 2018, 214 (04) : 507 - 512
  • [36] Resistance mechanisms to programmed cell death protein 1 and programmed death ligand 1 inhibitors
    Pezeshki, Parmida Sadat
    Mahdavi Sharif, Pouya
    Rezaei, Nima
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (12) : 1575 - 1590
  • [37] Development of Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Signaling Pathway
    Wang, Tianyu
    Wu, Xiaoxing
    Guo, Changying
    Zhang, Kuojun
    Xu, Jinyi
    Li, Zheng
    Jiang, Sheng
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (04) : 1715 - 1730
  • [38] Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer Reply
    Wang, Zhijie
    Zhao, Zhengyi
    Wang, Jie
    JAMA ONCOLOGY, 2020, 6 (07) : 1116 - +
  • [39] Multiomics Prediction of Response Rates to Therapies to Inhibit Programmed Cell Death 1 and Programmed Cell Death 1 Ligand 1
    Lee, Joo Sang
    Ruppin, Eytan
    JAMA ONCOLOGY, 2019, 5 (11) : 1614 - 1618
  • [40] Programmed cell death-1 and programmed cell death ligand-1 antibodies-induced dysthyroidism
    Jaafar, Jaafar
    Fernandez, Eugenio
    Alwan, Heba
    Philippe, Jacques
    ENDOCRINE CONNECTIONS, 2018, 7 (05): : R196 - R211
12345